[Sustainable development roadmap of Chinese antimalarial products]

Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2022 Apr 21;34(2):120-121. doi: 10.16250/j.32.1374.2022079.
[Article in Chinese]

Abstract

As the first country that has been certified malaria-free in the WHO Western Pacific Region for more than 3 decades, China should share its successful experiences of malaria control and provide globally recognized anti-malaria products by making full uses of its advantages in provision and production capacity of artemisinin raw materials, to fill the gaps of international demands for mosquito nets, rapid diagnostic reagents and antimalarial compounds. Increasing the investment of research and development of antimalarial products, building overseas bases for artemisinin raw material production, establishing international regulatory authority and promoting the local production of antimalarial products are needed to further promote the internationalization of Chinese antimalarial products, so as to achieve the equity and accessibility of Chinese antimalarial products in highburden regions for malaria.

[摘要] 作为30多年来WHO西太平洋区域第一个获得无疟疾认证的国家, 中国在向全球分享抗疟经验的同时, 还应积极发挥在青蒿素原料供给、生产产能等方面的优势, 提供国际认可的抗疟产品, 以填补国际社会对抗疟蚊帐、快速诊断试剂、复方治疗药物等产品需求的缺口。我国可通过加强抗疟产品研发投入、建立青蒿素原料种植和生产基地、树立国际监管权威、推动抗疟产品本地化生产等举措, 进一步推动各类抗疟产品的国际化进程, 实现抗疟产品在非洲等高疾病负担区域的公平可及。.

Keywords: Antimalarial product; Artemisinin; Internationalization; Malaria; Sustainable development.

MeSH terms

  • Antimalarials* / pharmacology
  • Antimalarials* / therapeutic use
  • Artemisinins* / therapeutic use
  • China
  • Drug Resistance
  • Humans
  • Malaria* / diagnosis
  • Malaria* / drug therapy
  • Malaria* / prevention & control
  • Plasmodium*
  • Sustainable Development

Substances

  • Antimalarials
  • Artemisinins